Bohai Pharmaceuticals Group (OTCQB:BOPH) is a Gold Medal manufacturer of medicines in China. Founded in 2004, Bohai fits with the modern, growing China; a more affluent middle class, while maintaining deep roots in a medical tradition lasting 2000 years.
(click to enlarge)
Photo sources: Bohai
The numbers are eye-popping
Since their 2010 U.S. listing, Bohai's revenues have grown from $59 mm to $178 mm (per issued guidance for fiscal 2014)(June 30th) and FY earnings are expected to leap to $1.22 per share. Thus in 2 months Bohai will be selling below 2X trailing earnings. Current (tangible) Book Value is $5.60, which places Bohai clearly (our vote, at least) as "the world's most undervalued stock".
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|